Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease

Objective: Current guidelines for secondary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend targeting a low-density lipoprotein cholesterol (LDL-C) of < 70 mg/dL. However, temporal trends and racial/ethnic- and sex-differences in achievement of LDL-C targets are not well de...

Full description

Bibliographic Details
Published in:	American Journal of Preventive Cardiology
Main Authors:	Danh Q. Nguyen, Neil Keshvani, Alvin Chandra, Pamela L. Alebna, Dave L. Dixon, Michael D. Shapiro, Erin D. Michos, Laurence S. Sperling, Ambarish Pandey, Anurag Mehta
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Subjects:	Secondary prevention LDL cholesterol ASCVD
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666667724000412

Similar Items

Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment
by: Dimitrios Delialis, et al.
Published: (2022-07-01)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
by: Yinchu Cheng, et al.
Published: (2022-10-01)

Stationary screen time, blood lipids, and atherosclerotic cardiovascular disease incidence
by: Yunjie Liu, et al.
Published: (2025-03-01)

Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Lawrence A. Leiter, et al.
Published: (2024-05-01)

LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review
by: Omer Akyol, et al.
Published: (2025-10-01)

Dyslipidemia management among patients with high and very high cardiovascular risk in Indonesia: a multi-center registry
by: Sunanto Ng, et al.
Published: (2025-09-01)

Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study
by: Xingdi Hu, et al.
Published: (2023-06-01)

Secondary Cardiovascular Disease Prevention Deficit Persists over the Years: A Multicenter Cross-Sectional Study Involving 1003 Consecutive Patients from Greece
by: Rodis D. Paparodis, et al.
Published: (2024-03-01)

Advancements in research to mitigate residual risk of atherosclerotic cardiovascular disease
by: Fan Shi, et al.
Published: (2025-08-01)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
by: David I. Feldman, et al.
Published: (2020-12-01)

A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease
by: Xiaochun Duan, et al.
Published: (2025-02-01)

Association of sdLDL-C/LDL-C ratio with atherosclerotic cardiovascular disease: a case-control study
by: Yuxin Yang, et al.
Published: (2025-06-01)

An equation for estimating low-density lipoprotein-triglyceride content and its use for cardiovascular disease risk stratification
by: Anna Wolska, et al.
Published: (2024-10-01)

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
by: Albosta MS, et al.
Published: (2023-07-01)

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
by: Tereza Altschmiedova, et al.
Published: (2022-03-01)

Impact of remnant cholesterol to high-density lipoprotein cholesterol ratio on risk of incident ASCVD: the Kailuan prospective cohort study
by: Yizhen Tan, et al.
Published: (2025-05-01)

Quo vadis, LDL cholesterol?
by: Cobos Andrés, et al.
Published: (2023-05-01)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
by: John H. Contois, et al.
Published: (2023-08-01)

Audit on lipid screening, management and target achievement in prevention of cardiovascular disease in patients attending a medical clinic in National Hospital Kandy: Are we on par with the guidelines?
by: F. N. Nasim, et al.
Published: (2023-02-01)

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience
by: Chad Gier, et al.
Published: (2024-01-01)

Measurement of LDL-Cholesterol in Serum by New Enzymatic Method
by: Surapon Tangvarasittichai, et al.
Published: (2020-08-01)

Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
by: Abdolreza Chary, et al.
Published: (2023-11-01)

LDL particle size and LDL and HDL cholesterol changes with dietary fat and cholesterol in healthy subjects
by: Peter M. Clifton, et al.
Published: (1998-09-01)

Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems
by: Nishant P. Shah, et al.
Published: (2024-11-01)

Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease
by: Boqun Shi, et al.
Published: (2022-10-01)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
by: Aleksandra Gąsecka, et al.
Published: (2021-01-01)

Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins
by: Fei Luo, et al.
Published: (2024-01-01)

Irbesartan; An Antihypertensive Drug Reduces LDL-Cholesterol in Diet Induced Hyperlipidemic Rabbits
by: Sabeen Shakir , Akbar Waheed , Noureen Hafeez
Published: (2016-09-01)

Hispanic/Latino ethnic background and genetic ancestry in relation to atherosclerotic cardiovascular disease risk estimation: Findings from the Multi-Ethnic Study of Atherosclerosis (MESA)
by: Bede N. Nriagu, et al.
Published: (2025-09-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Comparison of LDL-cholesterol using the Friedewald calculation and homogeneous enzymatic assay
by: P Choosongsang, et al.
Published: (2008-01-01)

Impact of the COVID-19 pandemic on the management of risk factors in patients with stable atherosclerotic vascular disease
by: Dean G. Karalis, et al.
Published: (2023-06-01)

Atherosclerotic cardiovascular disease events among adults with high predicted risk without established risk factors
by: Nathan Kong, et al.
Published: (2024-03-01)

Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients
by: Christeen Samuel, et al.
Published: (2023-06-01)

Incidence and risk factors regarding atherosclerotic cardiovascular disease in middle-aged and elderly people with HIV treated in Chongqing, China
by: Min Liu, et al.
Published: (2024-12-01)

The Efficacy of Non-Pharmacological Interventions in Reducing Elevated Serum LDL Cholesterol Levels: A Review Paper
by: Justyna Janikowska, et al.
Published: (2025-05-01)

Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease
by: Zain Jafar, et al.
Published: (2020-09-01)

Choosing the right equation for calculating indirect LDL-Cholesterol (LDL-C) in adult Pakistani population: Evaluation of seven equations using big data analytics
by: Syed Bilal Hashmi, et al.
Published: (2024-08-01)

Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol
by: Maureen Sampson, et al.
Published: (2022-07-01)

Reduced plasma levels of neuregulin-1 are associated with adverse outcomes in patients with atherosclerotic cardiovascular disease
by: Jie Liu, et al.
Published: (2025-07-01)